qXR-LN

by Qure.ai  · Based in India → — AI assistance for Accelerated Healthcare
Emergency Medicine Pulmonology Radiology

Regulatory Status Disclosed

Overview

qXR-LN by Qure.ai is a cutting-edge computer-aided detection (CAD) software designed to identify and highlight regions indicative of suspected pulmonary nodules, ranging from 6 to 30 mm in size, on frontal chest X-rays of adults. This AI tool acts as a secondary reader, assisting physicians such as radiologists, pulmonologists, and emergency room physicians in the review of chest X-rays, particularly for the incidental detection of lung nodules. It is not intended to be used on a standalone basis for clinical decision-making or to rule out target conditions, but rather to complement the expertise of medical professionals by providing adjunctive information. qXR-LN integrates seamlessly into existing standard of care workflows, offering pre-read assistance and serving as a passive notification system for worklist prioritization, ultimately aiming to support earlier identification of lung cancers and improve patient outcomes.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered detection and localization of lung nodules (6-30mm) on chest X-rays
  • Acts as a secondary reader to aid physicians
  • Provides pre-read assistance within seconds
  • Identifies incidental findings for lung cancer
  • Integrates into existing standard of care workflow for worklist prioritization
  • Can be deployed on cloud or on-premise
  • Offers multilingual support on mobile and web (for qXR platform)
  • Produces DICOM format outputs
  • Compatible with any DICOM viewer or PACS
  • Clinically validated in multiple geographies

Use Cases

  • Early detection of lung cancer
  • Screening for pulmonary nodules on chest X-rays
  • Assisting radiologists in reviewing chest X-rays
  • Aiding pulmonologists and ER physicians in nodule detection
  • Workflow triage by flagging suspected findings
  • Reducing time to diagnosis in critical settings

What Physicians Need to Know

Key Capabilities
qXR-LN is an AI-powered computer-aided detection software designed to identify and localize suspected pulmonary nodules ranging from 6 to 30 mm in size on chest X-rays. It acts as a second reader for physicians, assisting in the review of frontal chest radiographs of adults. The tool can help detect subtle anatomical anomalies that might otherwise go unnoticed, especially in asymptomatic patients. It also provides a Lung Nodule Malignancy Score (qXR-LNMS) to assess the likelihood of malignancy in lung nodules detected on chest X-rays, supporting clinical decision-making.
Clinical Utility
qXR-LN aims to enhance early detection of lung cancer by identifying potentially malignant pulmonary nodules. It can improve the performance of radiologists, pulmonologists, and emergency room physicians in detecting lung nodules. The tool has shown a high negative predictive value (93.5% in one study) for ruling out malignancy, making it valuable for triage. It can also serve as a safety net for chest radiograph interpretation, helping to identify lung cancers initially missed on routine X-rays.
Integration Options
qXR-LN is hardware agnostic and offers flexible deployment solutions, including PACS integration, web, and on-premise options. It produces DICOM format outputs that allow users to view the presence and location of lung nodules and can be used with any DICOM viewer or PACS.
Compliance Status
qXR-LN is US FDA 510(k) cleared. Qure.ai also adheres to ISO 13485 standards and has obtained CE marking for some of its products. The company is compliant with HIPAA and GDPR.
Pricing Model
Qure.ai utilizes an enterprise pricing model, and specific pricing for qXR-LN requires contacting their sales department.
User Experience
The tool is designed to aid radiologists, pulmonologists, and ER physicians in reviewing frontal chest radiographs. It provides adjunctive information and is not a substitute for the original chest radiographic image or standalone clinical decision-making.
Support Quality
unknown
Implementation Complexity
qXR-LN offers flexible deployment solutions, including cloud or on-premise, and integrates into existing standard of care workflows.
Evidence Base
Qure.ai conducted two pivotal studies to establish the safety and efficacy of qXR-LN, demonstrating standalone performance with an AUC of 94% for nodule detection. A multi-reader, multi-case clinical validation study showed statistically significant improvement in pulmonary nodule detection across various reader groups (radiologists, pulmonologists, ER physicians). The CREATE study, a multi-country observational study, evaluated qXR-LNMS and demonstrated strong predictive performance with a Negative Predictive Value (NPV) of 93.5%. A retrospective study at University Hospitals Cleveland Medical Center highlighted qXR-LN's potential to identify missed lung cancers on routine chest X-rays, achieving an AI-enhanced detection rate of 26.7%.
Physician Tip

qXR-LN serves as a valuable 'second pair of eyes' for detecting lung nodules on chest X-rays, potentially improving early lung cancer detection. It can be particularly useful for triaging patients due to its high negative predictive value, helping to rule out malignancy. Physicians should remember that qXR-LN provides adjunctive information and should not be used as a standalone diagnostic tool. Integrating this AI tool into existing workflows can help prioritize cases and potentially reduce diagnostic oversights, especially in high-volume settings or when reviewing incidental findings.

qXR-LN is designed for seamless integration into existing radiology workflows. It is hardware agnostic and can be deployed on-premise or via the web, with direct PACS integration. The output is in DICOM format, ensuring compatibility with standard DICOM viewers and PACS systems. This flexibility allows for its adoption without significant changes to current imaging infrastructure.

Details

Category Oncology AI, Radiology & Imaging AI
Pricing Unknown
DeploymentCloud or on-premise.
Mobile AppYes
API Available Yes
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
GDPR Yes AI-estimated
Integrations
EHR Not specified
Specialties Emergency Medicine, Pulmonology, Radiology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2023-12-22K231805 510(k)qXR-LN

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate qXR-LN

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for qXR-LN.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

qXR-LN is an AI-powered computer-aided detection software designed to identify and highlight suspected pulmonary nodules (6-30 mm) on frontal chest X-rays in adults. It acts as a 'second reader' to assist radiologists, pulmonologists, and ER physicians in reviewing chest radiographs, aiming to improve the early detection of potentially malignant lung nodules.
qXR-LN has received US FDA 510(k) clearance. Qure.ai's software development processes are also ISO 13485:2016 certified, ensuring adherence to quality, safety, and regulatory standards for medical devices.
qXR-LN is intended for use in the incidental adult population and is designed to detect pulmonary nodules between 6 and 30 mm. It provides adjunctive information only and is not a substitute for the original chest radiographic image or a definitive diagnosis.
While qXR-LN is a specific AI solution for lung nodule detection on X-rays, other AI tools and platforms exist within the broader lung cancer care continuum. Qure.ai itself offers qCT LN Quant for analyzing lung nodules on CT scans and qTrack for multi-modality lung nodule management. Other companies also offer AI solutions for lung CT analysis, such as Rayscape, Coreline, contextflow, Riverain, Infervision, and DeepHealth.
In pivotal studies, qXR-LN demonstrated a standalone performance with an Area Under the Curve (AUC) of 94% for nodule detection. A multi-reader, multi-case clinical validation study showed that qXR-LN significantly enhanced pulmonary nodule detection across various reader groups, including radiologists, pulmonologists, and emergency room physicians. Recent research also indicates that qXR-LN contributed to a 26.7% increase in nodule detection rates and identified nodules related to early-stage and missed Stage 1A lung cancers.

Related Tools

VERITON CT 400 Series Digital SPECT/CT System (VERITON CT 416/464)
Spectrum Dynamics Medical
Oncology AI
The VERITON CT 400 Series is a digital SPECT/CT system with a 360-degree gantry and 12 swiveling CZT detectors, offering high sensitivity and quantitative accuracy for a wide range of nuclear medicine applications, including advanced theranostics imaging.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
BIOGRAPH One
Siemens Healthineers AG
Oncology AI
BIOGRAPH One is a second-generation PET/MR scanner designed to transform PET/MR image quality for a new era, combining high PET precision with powerful MR performance. It enables simultaneous visualization of organ location, function, and cellular metabolism, offering faster image acquisition times and more efficient workflows than previous generations of PET/MR scanners.
Claire™ OCT System
Perimeter Medical Imaging AI
Oncology AI
Perimeter Medical Imaging AI is a medical technology company driven to transform cancer surgery with ultra-high resolution, real-time, advanced imaging tools that address unmet medical needs.S. for intraoperative breast cancer margin assessment.
syngo.via RT Image Suite VC10
Varian Medical Systems, Inc.
Clinical Decision Support & Reference
syngo.via RT Image Suite VC10 offers advanced imaging and workflow solutions for precise and efficient radiation therapy planning.

See all Oncology AI tools →

More from Qure.ai Technologies

qCT LN Quant
Qure.ai
Oncology AI
Qure.
qER
Qure.ai
Neurology AI
qER by Qure.
qER-CTA
Qure AI
Neurology AI
Qure.
qER-Quant
Qure AI
Neurology AI
Qure.ai's qER-Quant is an AI-powered software for automated analysis and quantification of non-contrast head CT images, aiding in the assessment and monitoring of neurological conditions like TBI, stroke, and hydrocephalus.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-12 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.